Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells

Michaela Oeller (First author), Sandra Laner-Plamberger (Co-author), Sarah Hochmann (Co-author), Nina Ketterl (Co-author), Martina Feichtner (Co-author), Gabriele Brachtl (Co-author), Anna Hochreiter (Co-author), Cornelia Scharler (Co-author), Lara Sophie Bieler (Co-author), Pasquale Romanelli (Co-author), Sebastien Couillard-Despres (Co-author), Elisabeth Russe (Co-author), Katharina Schallmoser* (Co-author), Dirk Strunk (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Articlepeer-review

41 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1421-1434
JournalTheranostics
Volume8
Issue number5
DOIs
Publication statusPublished - 2018

Keywords

  • MESENCHYMAL STEM-CELLS
  • MEDIATED INFLAMMATORY REACTION
  • FETAL BOVINE SERUM
  • ISLET TRANSPLANTATION
  • HUMAN BLOOD
  • IN-VITRO
  • THERAPY
  • PROPAGATION
  • MONOCYTES
  • EXPANSION

Cite this